NCT00748306View on ClinicalTrials.gov

Study in Mild Asthmatic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Asthma
Interventions
DRUG

GSK2190915 - 100mcg

GSK2190915 is a high affinity 5-lipoxygenase-activating protein (FLAP) inhibitor

DRUG

Placebo

Matching Intervention Drug

Trial Locations (4)

2333 CL

GSK Investigational Site, Leiden

M23 9LT

GSK Investigational Site, Manchester

NW10 7EW

GSK Investigational Site, London

W1G 8HU

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY